1Y Annualised Return
▲67.67%
3Y Annualised Return
▲46.81%
5Y Annualised Return
▲47.27%
10Y Annualised Return
▲18.50%
|
|
|
Fortis Healthcare Limited was incorporated on February 28, 1996, by the Singh brothers as an extension of their pharmaceutical legacy. The company is headquartered at the Fortis Memorial Research Institute in Gurgaon, with its registered office in Mohali, Punjab. It operates 36 healthcare facilities across India, Dubai, and Sri Lanka, offering a range of medical services. Fortis is listed on both the Bombay Stock Exchange (BSE: 532843) and the National Stock Exchange (NSE: FORTISEQ), and is backed by Malaysia’s IHH Healthcare.
Fortis Healthcare operates through three primary segments: hospitals, diagnostics, and pharmacies. The hospital division provides multi-specialty tertiary and quaternary care services including cardiology, oncology, orthopaedics, neurology, and more. The diagnostics arm, Agilus Diagnostics, offers pathology and imaging services through a broad network. Its pharmacy business supports the hospital ecosystem and generates additional retail revenue. The company earns primarily through inpatient and outpatient services, diagnostics, pharmacy sales, and day-care procedures. Medical tourism contributes to the revenue as international patients seek cost-effective, high-quality treatment across Fortis facilities.
Over the past
Market Cap (in crs)
72,672.27
Face Value
10
Turnover (in lacs)
15,366.28
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
2166.72 Cr | 2007.2 Cr | 1928.26 Cr | 1988.39 Cr | 1858.9 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
7849.69 Cr | 6931.17 Cr | 6359.35 Cr | 5744.95 Cr | 4076.68 Cr | 4684.96 Cr |
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
263.86 Cr | 183.38 Cr | 252.24 Cr | 188.85 Cr | 173.39 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
797.86 Cr | 635.71 Cr | 611.15 Cr | 765.8 Cr | -103.73 Cr | 79.32 Cr |
Fortis Healthcare Ltd reported a 21.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 16.6%.
Its expenses for the quarter were up by 20.6% QoQ and 12.4% YoY.
The net profit increased 31.3% QoQ and increased 53.3% YoY.
The earnings per share (EPS) of Fortis Healthcare Ltd stood at 3.5 during Q1 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 1102813 Rs | 1643801 Rs |
Week Rs | 766855 Rs | 1224734 Rs |
Month Rs | 901315 Rs | 1475358 Rs |
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7,888.00 | 1,13,417.34 | 6001 | 7980 | 7,852.50 | -0.52% | 0.85% | 28.12% | 12.56% | 84.31% | 0.16% | 83.85 | 92.76 | 12.97 | |
1,807.10 | 36,930.04 | 1185 | 2370.2 | 1,785.50 | 1.39% | -0.27% | 14.51% | 40.76% | 158.73% | 0.25% | 85.45 | 92.76 | 16.88 | |
614.30 | 31,828.17 | 387.1 | 675 | 619.90 | -4.37% | 1.44% | 44.56% | 48.42% | 148.00% | 0.78% | 98.66 | 92.76 | 8.47 | |
1,153.80 | 1,12,176.64 | 888.9 | 1314.3 | 1,158.70 | -2.28% | -5.48% | 15.62% | 19.60% | 165.73% | 0.13% | 146.74 | 92.76 | 13.53 | |
742.95 | 29,728.32 | 474.05 | 798.4 | 757.00 | -1.68% | -0.28% | 24.74% | 32.19% | 203.68% | 0.00% | 101.66 | 92.76 | 13.72 | |
1,377.50 | 37,025.88 | 935.5 | 1456.5 | 1,360.30 | 0.50% | 0.25% | 16.72% | 22.41% | 0.00% | 0.00% | 73.88 | 92.76 | 10.59 |
Fortis Healthcare share price is ₹962.6 in NSE and ₹962.65 in BSE as on 17/9/2025.
Fortis Healthcare share price in the past 1-year return was 59.41. The Fortis Healthcare share hit a 1-year low of Rs. 572 and a 1-year high of Rs. 983.2.
The market cap of Fortis Healthcare is Rs. 72672.27 Cr. as of 17/9/2025.
The PE ratios of Fortis Healthcare is 413.15 as of 17/9/2025.
The PB ratios of Fortis Healthcare is 8 as of 17/9/2025
The Mutual Fund Shareholding in Fortis Healthcare was 26.07% at the end of 17/9/2025.
You can easily buy Fortis Healthcare shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Fortis Healthcare share price is ₹983.2 and ₹572 as of 17/9/2025.
The earnings per share (EPS) of Fortis Healthcare stood at 3.5 during Q1 FY 2025-26.
Please be aware that Fortis Healthcare stock prices are subject to continuous fluctuations due to various factors.